These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26086586)

  • 1. From rubella to rotavirus, and beyond.
    Vesikari T
    Hum Vaccin Immunother; 2015; 11(6):1302-5. PubMed ID: 26086586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. India to introduce rubella and rotavirus vaccines and inactivated polio vaccine.
    Mudur G
    BMJ; 2014 Jul; 349():g4844. PubMed ID: 25062782
    [No Abstract]   [Full Text] [Related]  

  • 3. Japanese encephalitis, rotavirus, rubella and injectable polio vaccine: Four new tools in the immunization programme of India.
    Roy P
    Natl Med J India; 2014; 27(5):297-8. PubMed ID: 26037449
    [No Abstract]   [Full Text] [Related]  

  • 4. Rubella elimination, the Canadian experience.
    Macey JF; Tam T; Lipskie T; Tipples G; Eisbrenner T
    J Infect Dis; 2011 Sep; 204 Suppl 2():S585-92. PubMed ID: 21954251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of rotavirus vaccines in Asia--are there lessons to be learnt?
    Mirzayeva R; Steele AD; Parashar UD; Zaman K; Neuzil KM; Nelson EA
    Vaccine; 2009 Nov; 27 Suppl 5():F120-9. PubMed ID: 19931711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fanuel Bickton talks to Desiree Witte on her clinical research experience with vaccines in Malawi.
    Malawi Med J; 2017 Mar; 29(1):74-76. PubMed ID: 28567207
    [No Abstract]   [Full Text] [Related]  

  • 7. Current lessons from 20th century serosurveillance data on rubella.
    Cooper LZ
    Clin Infect Dis; 2001 Oct; 33(8):1287. PubMed ID: 11565066
    [No Abstract]   [Full Text] [Related]  

  • 8. Rotavirus: realising the potential of a promising vaccine.
    Nelson EA; Glass RI
    Lancet; 2010 Aug; 376(9741):568-70. PubMed ID: 20692032
    [No Abstract]   [Full Text] [Related]  

  • 9. Foreword: ESPID/ESPGHAN evidence-based recommendations for rotavirus vaccination in Europe.
    Vesikari T
    J Pediatr Gastroenterol Nutr; 2008 May; 46 Suppl 2():v-vi. PubMed ID: 18460975
    [No Abstract]   [Full Text] [Related]  

  • 10. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
    Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
    Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus vaccines, an update.
    Can Commun Dis Rep; 2003 May; 29(9):82-3. PubMed ID: 12739276
    [No Abstract]   [Full Text] [Related]  

  • 12. [A rotavirus vaccine--Rotarix. Oral administration].
    Duh PD; Macken E
    J Pharm Belg; 2006; 61(4):121-2. PubMed ID: 17263194
    [No Abstract]   [Full Text] [Related]  

  • 13. Human rotavirus vaccines: too early for the strain to tell.
    Grimwood K; Kirkwood CD
    Lancet; 2008 Apr; 371(9619):1144-5. PubMed ID: 18395562
    [No Abstract]   [Full Text] [Related]  

  • 14. Rotavirus vaccines for children in developing countries: understanding the science, maximizing the impact, and sustaining the effort.
    Neuzil KM; Parashar UD; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A1-2. PubMed ID: 22520117
    [No Abstract]   [Full Text] [Related]  

  • 15. Lessons learned from integrated surveillance of measles and rubella in the Caribbean.
    Irons B; Morris-Glasgow V; Andrus JK; Castillo-Solórzano C; Dobbins JG;
    J Infect Dis; 2011 Sep; 204 Suppl 2():S622-6. PubMed ID: 21954257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia.
    Snelling TL; Andrews RM; Kirkwood CD; Culvenor S; Carapetis JR
    Clin Infect Dis; 2011 Jan; 52(2):191-9. PubMed ID: 21288843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS; Block SL
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RotaTeq: a new oral rotavirus vaccine.
    Med Lett Drugs Ther; 2006 Jul; 48(1240):61-3. PubMed ID: 16874281
    [No Abstract]   [Full Text] [Related]  

  • 19. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America.
    Tregnaghi MW; Abate HJ; Valencia A; Lopez P; Da Silveira TR; Rivera L; Rivera Medina DM; Saez-Llorens X; Gonzalez Ayala SE; De León T; Van Doorn LJ; Pilar Rubio MD; Suryakiran PV; Casellas JM; Ortega-Barria E; Smolenov IV; Han HH;
    Pediatr Infect Dis J; 2011 Jun; 30(6):e103-8. PubMed ID: 21378594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world impact of rotavirus vaccination.
    Patel MM; Steele D; Gentsch JR; Wecker J; Glass RI; Parashar UD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S1-5. PubMed ID: 21183833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.